Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties.

In this issue, CEO Karin Bryder comments on the company’s ongoing share issue for a continued aggressive international expansion with Efemia, as well as the company’s progress in the beginning of 2020 including a first framework agreement in Sweden and approvements for subscription with reimbursement in Norway and the Netherlands.

To read the newsletter, and subscribe to receive upcoming issues, follow this link:

The newsletter is published in Swedish and English, with a flexible publishing frequency based on Invent Medic’s news flow. It is produced together with the company’s IR communication partner Honeybadger, Invent Medic encourages feedback and requests on topics for upcoming issues of the newsletter.

Download: Release